Nicola Trotta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicola Trotta has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Antonin Rovai
Laboratoire de neuroanatomie et neuroimagerie translationnelles (LN2T), Neuroscience Institute, Université libre de Bruxelles (ULB), Brussels, Belgium
4 shared publications - Serge Goldman
Université Libre de Bruxelles (ULB)
4 shared publications - Gil Leurquin-Sterk
Department of Nuclear Medicine, Hôpitaux Universitaires de Bruxelles – Erasme, Brussels, Belgium
3 shared publications Serge Goldman
Department of Nuclear Medicine, Hôpital Erasme Université libre de Bruxelles (ULB) Brussels Belgium
3 shared publications- Vincent Wens
ULB, UNI, Laboratoire de Neuroanatomie et Neuroimagerie translationnelles (LN2T), Brussels, Belgium
3 shared publications Xavier De Tiège
Université libre de Bruxelles (ULB), UNI - ULB Neuroscience Institute, Laboratoire de Neuroanatomie et Neuroimagerie translationnelles (LN(2)T), Route de Lennik 808, 1070 Bruxelles, Belgium; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B.), CUB Hôpital Erasme, Service of Translational Neuroimaging, Route de Lennik 808, 1070 Bruxelles, Belgium
3 shared publications
Latest Publications
- Open Access
- 10 June 2026
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 25 (03) , 208-218
Limited Added Prognostic Value of Choline PET/CT in Treatment-Naïve Hepatocellular Carcinoma
This retrospective study aimed to assess whether choline PET/CT provides additional independent prognostic value compared with magnetic resonance imaging (MRI) and [18F]FDG PET/CT in treatment-naïve patients with hepatocellular carcinoma (HCC). A total of 78 treatment-naïve patients with predominantly single-lesion and early-stage HCC who underwent MRI, [18F]FDG PET/CT, and choline PET/CT were retrospectively included. Higher than median MRI-, choline and [18F]FDG PET/CT-derived tumor volumes were associated with poorer overall survival (OS) in univariate analyses. An MRI-derived tumor volume > 17.81 mL was associated with worse OS (p = 0.005; hazard ratio [HR], 3.15; 95% confidence interval [CI], 1.41–7.03), as were choline PET/CT tumor volume > 8.4 mL (p = 0.04; HR, 2.27; 95% CI, 1.03–5.01) and [18F]FDG positivity (p = 0.02; HR, 2.74; 95% CI, 1.11–6.81). After multivariate analysis with correction for multiple testing, only MRI-derived tumor volume remained an independent predictor of OS. Although associated with OS in univariate analyses, choline PET-derived metrics did not retain statistical significance after adjustment, suggesting limited incremental prognostic information beyond MRI-derived tumor burden. Liver transplantation and hepatectomy were associated with superior survival compared with locoregional therapies (p = 0.006). No significant correlations were observed between imaging parameters and α-fetoprotein (AFP) levels or ALBI score (all p > 0.05). Interaction analyses did not detect any significant modification of the prognostic effect of choline PET imaging biomarkers by AFP levels, ALBI score, or Child–Pugh class. Treatment modality emerged as the strongest prognostic factor in the penalized model using least absolute shrinkage and selection operator regularization, while choline PET-derived parameters did not show independent prognostic value. Choline PET/CT did not demonstrate additional independent prognostic value beyond MRI or [18F]FDG PET/CT in this cohort of treatment-naïve patients with predominantly early-stage and single-lesion HCC.
- 10 June 2026
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 25 (03) , 208-218
Open AccessLimited Added Prognostic Value of Choline PET/CT in Treatment-Naïve Hepatocellular Carcinoma
This retrospective study aimed to assess whether choline PET/CT provides additional independent prognostic value compared with magnetic resonance imaging (MRI) and [18F]FDG PET/CT in treatment-naïve patients with hepatocellular carcinoma (HCC). A total of 78 treatment-naïve patients with predominantly single-lesion and early-stage HCC who underwent MRI, [18F]FDG PET/CT, and choline PET/CT were retrospectively included. Higher than median MRI-, choline and [18F]FDG PET/CT-derived tumor volumes were associated with poorer overall survival (OS) in univariate analyses. An MRI-derived tumor volume > 17.81 mL was associated with worse OS (p = 0.005; hazard ratio [HR], 3.15; 95% confidence interval [CI], 1.41–7.03), as were choline PET/CT tumor volume > 8.4 mL (p = 0.04; HR, 2.27; 95% CI, 1.03–5.01) and [18F]FDG positivity (p = 0.02; HR, 2.74; 95% CI, 1.11–6.81). After multivariate analysis with correction for multiple testing, only MRI-derived tumor volume remained an independent predictor of OS. Although associated with OS in univariate analyses, choline PET-derived metrics did not retain statistical significance after adjustment, suggesting limited incremental prognostic information beyond MRI-derived tumor burden. Liver transplantation and hepatectomy were associated with superior survival compared with locoregional therapies (p = 0.006). No significant correlations were observed between imaging parameters and α-fetoprotein (AFP) levels or ALBI score (all p > 0.05). Interaction analyses did not detect any significant modification of the prognostic effect of choline PET imaging biomarkers by AFP levels, ALBI score, or Child–Pugh class. Treatment modality emerged as the strongest prognostic factor in the penalized model using least absolute shrinkage and selection operator regularization, while choline PET-derived parameters did not show independent prognostic value. Choline PET/CT did not demonstrate additional independent prognostic value beyond MRI or [18F]FDG PET/CT in this cohort of treatment-naïve patients with predominantly early-stage and single-lesion HCC.
- Open Access
- 20 February 2025
- Published by Science Publishing Group in International Journal of Neurosurgery
- Vol. 9 (1) , 30-40
Gamma-Knife Thalamotomy for Essential and Parkinsonian Tremor: Predicting Response to Treatment Using Pre-Therapeutic Cerebral FDG-PET
Essential tremor and parkinsonian tremor affect approximately 5–7% of individuals over the age of 65. Pharmacological therapies yield sustained clinical improvement in only about 50% of cases. For patients ineligible for deep brain stimulation, Gamma Knife thalamotomy (GKVIM) offers a non-invasive alternative, demonstrating a tremor reduction efficacy of 70–80%, typically with a latency of approximately 4.8 months. This study aimed to identify regional cerebral metabolic patterns predictive of clinical response to GKVIM using [¹ 8 F]-FDG positron emission tomography (FDG-PET). Fifteen consecutive patients diagnosed with essential tremor (n=10) or parkinsonian tremor (n=5) underwent preoperative cerebral FDG-PET imaging within 24 hours prior to GKVIM at Erasme University Hospital between January 2020 and January 2023. All patients were clinically followed for a minimum of six months (mean follow-up: 9 ± 3 months) by experienced neurologists or neurosurgeons. Statistical Parametric Mapping (SPM) was used to compare metabolic patterns between treatment responders (n=11; 73%) and non-responders (n=4) to identify potential predictors of therapeutic response. As a secondary objective, metabolic differences between patients with essential tremor and healthy controls (n=54) were analyzed to explore neurobiological correlates of disease pathophysiology. Those analysis revealed that responders exhibited significant hypometabolism in the prefrontal cortex and supramarginal gyrus, alongside cerebellar hypermetabolism. In the secondary analysis, patients with essential tremor demonstrated distinct metabolic alterations, notably involving the inferior olivary nuclei. This study thus identifies specific regional cerebral metabolic patterns associated with favourable clinical response to Gamma Knife thalamotomy, suggesting potential neuroimaging biomarkers for patient selection. Moreover, the observed metabolic changes provide additional insight into the pathophysiological mechanisms underlying essential tremor.
- 20 February 2025
- Published by Science Publishing Group in International Journal of Neurosurgery
- Vol. 9 (1) , 30-40
Open AccessGamma-Knife Thalamotomy for Essential and Parkinsonian Tremor: Predicting Response to Treatment Using Pre-Therapeutic Cerebral FDG-PET
Essential tremor and parkinsonian tremor affect approximately 5–7% of individuals over the age of 65. Pharmacological therapies yield sustained clinical improvement in only about 50% of cases. For patients ineligible for deep brain stimulation, Gamma Knife thalamotomy (GKVIM) offers a non-invasive alternative, demonstrating a tremor reduction efficacy of 70–80%, typically with a latency of approximately 4.8 months. This study aimed to identify regional cerebral metabolic patterns predictive of clinical response to GKVIM using [¹ 8 F]-FDG positron emission tomography (FDG-PET). Fifteen consecutive patients diagnosed with essential tremor (n=10) or parkinsonian tremor (n=5) underwent preoperative cerebral FDG-PET imaging within 24 hours prior to GKVIM at Erasme University Hospital between January 2020 and January 2023. All patients were clinically followed for a minimum of six months (mean follow-up: 9 ± 3 months) by experienced neurologists or neurosurgeons. Statistical Parametric Mapping (SPM) was used to compare metabolic patterns between treatment responders (n=11; 73%) and non-responders (n=4) to identify potential predictors of therapeutic response. As a secondary objective, metabolic differences between patients with essential tremor and healthy controls (n=54) were analyzed to explore neurobiological correlates of disease pathophysiology. Those analysis revealed that responders exhibited significant hypometabolism in the prefrontal cortex and supramarginal gyrus, alongside cerebellar hypermetabolism. In the secondary analysis, patients with essential tremor demonstrated distinct metabolic alterations, notably involving the inferior olivary nuclei. This study thus identifies specific regional cerebral metabolic patterns associated with favourable clinical response to Gamma Knife thalamotomy, suggesting potential neuroimaging biomarkers for patient selection. Moreover, the observed metabolic changes provide additional insight into the pathophysiological mechanisms underlying essential tremor.
- 4 February 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 173, 256-267
Neural correlates of semantic and phonemic variants of verbal fluency tasks: A combined MEG and fMRI study
- 4 February 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 173, 256-267
Neural correlates of semantic and phonemic variants of verbal fluency tasks: A combined MEG and fMRI study
- 8 August 2022
- Published by Wiley in Medical Physics
- Vol. 49 (12) , 7567-7582
Comparison of PMT‐based TF64 and SiPM‐based Vereos PET/CT systems for 90Y imaging and dosimetry optimization: A quantitative study
Background: Selective internal radiotherapy based on transarterial radioembolization (TARE) with yttrium‐90 (90Y) microspheres is an established treatment for primary or metastatic liver disease.Purpose: The objective of this work is to optimize the dosimetry of patients treated with 90Y TARE, using positron emission tomography (PET) images.Methods: The NEMA 2012 PET phantom was filled with nearly 3.9 GBq of 90Y activity and acquired at days 0, 3, 5, 7, and 9 on a classic time‐of‐flight PET/computed tomography (CT) scanner (Philips TF64) and on a silicon photomultiplier (SiPM)‐based PET/CT scanner (Philips Vereos). Acquisitions were carried on following the guidelines proposed in a previously published multicentric trial and images were reconstructed by varying and combining the available parameters. Comparisons were performed to identify the best set(s) of parameters leading to the most accurate 90Y‐PET image(s), in terms of activity distribution. Then, for both scanners, the best images were analyzed with Simplicit90Y, a personalized dosimetry software using multicompartmental Medical Internal Radiation Dose model. The comparison between measured and true doses allowed to identify the image granting the most consistent dose estimations and, therefore, to designate the set of parameters to be applied on patients’ data for the reconstruction of optimized clinical images. Posttreatment dosimetry of four patients was then realized with Simplicit90Y using optimized imaging datasets.Results: Based on activity distribution comparisons and dose estimations over phantom and patients data, the SiPM‐based PET/CT system appeared more suitable than the photomultiplier tube‐based TF64 for 90Y‐PET imaging. With the SiPM‐based PET/CT system, reconstructed images with a 2‐mm voxel size combined with the application of the point spread function correction led to the most accurate results for quantitative 90Y measures.Conclusions: For the SiPM‐based PET/CT scanner, an optimized set of reconstruction parameters has been identified and applied on patients’ data in order to generate the most accurate image to be used for an improved personalized 90Y‐PET dosimetry, ensuring a reliable evaluation of the delivered doses.
- 8 August 2022
- Published by Wiley in Medical Physics
- Vol. 49 (12) , 7567-7582
Comparison of PMT‐based TF64 and SiPM‐based Vereos PET/CT systems for 90Y imaging and dosimetry optimization: A quantitative study
Background: Selective internal radiotherapy based on transarterial radioembolization (TARE) with yttrium‐90 (90Y) microspheres is an established treatment for primary or metastatic liver disease.Purpose: The objective of this work is to optimize the dosimetry of patients treated with 90Y TARE, using positron emission tomography (PET) images.Methods: The NEMA 2012 PET phantom was filled with nearly 3.9 GBq of 90Y activity and acquired at days 0, 3, 5, 7, and 9 on a classic time‐of‐flight PET/computed tomography (CT) scanner (Philips TF64) and on a silicon photomultiplier (SiPM)‐based PET/CT scanner (Philips Vereos). Acquisitions were carried on following the guidelines proposed in a previously published multicentric trial and images were reconstructed by varying and combining the available parameters. Comparisons were performed to identify the best set(s) of parameters leading to the most accurate 90Y‐PET image(s), in terms of activity distribution. Then, for both scanners, the best images were analyzed with Simplicit90Y, a personalized dosimetry software using multicompartmental Medical Internal Radiation Dose model. The comparison between measured and true doses allowed to identify the image granting the most consistent dose estimations and, therefore, to designate the set of parameters to be applied on patients’ data for the reconstruction of optimized clinical images. Posttreatment dosimetry of four patients was then realized with Simplicit90Y using optimized imaging datasets.Results: Based on activity distribution comparisons and dose estimations over phantom and patients data, the SiPM‐based PET/CT system appeared more suitable than the photomultiplier tube‐based TF64 for 90Y‐PET imaging. With the SiPM‐based PET/CT system, reconstructed images with a 2‐mm voxel size combined with the application of the point spread function correction led to the most accurate results for quantitative 90Y measures.Conclusions: For the SiPM‐based PET/CT scanner, an optimized set of reconstruction parameters has been identified and applied on patients’ data in order to generate the most accurate image to be used for an improved personalized 90Y‐PET dosimetry, ensuring a reliable evaluation of the delivered doses.
- Open Access
- 5 March 2022
- Published by Elsevier in NeuroImage
- Vol. 253, 119061
The role of reading experience in atypical cortical tracking of speech and speech-in-noise in dyslexia
- 5 March 2022
- Published by Elsevier in NeuroImage
- Vol. 253, 119061
Open AccessThe role of reading experience in atypical cortical tracking of speech and speech-in-noise in dyslexia
- 19 August 2021
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 63 (5) , 785-791
18F-fluorocholine PET/CT is more sensitive than 11C-methionine PET/CT for the localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism
Purpose: Preoperative molecular imaging is paramount to direct surgery in primary hyperparathyroidism (pHTP). We investigate the diagnostic performance of 18F-fluorocholine (18F-FCH) PET/CT compared to 11C-methionine (11C-MET) PET/CT for the localization of hyperfunctioning parathyroid tissue in patients with pHTP and negative or inconclusive 99mTc-sestaMIBI SPECT (MIBI) findings. Materials and Methods: Fifty-eight patients with biochemical evidence of pHTP and negative or inconclusive MIBI were referred for pre-surgical detection and localization of hyperfunctioning parathyroid tissue by 11C-MET- and 18F-FCH-PET/CT. The PET/CT results were classified into 3 categories (positive, inconclusive or negative) based on the nodular aspect of tracer uptake and the visualisation of corresponding nodules on CT. The PET/CT results were correlated with the surgical and histopathological findings used as gold standard. Results: Fifty-three patients were included for analysis. 18F-FCH-PET/CT was positive in 39 patients (74%), inconclusive in 5 (9%) and negative in 9 (17%), compared to 25 (47%), 12 (23%) and 16 (30%) respectively for 11C-MET-PET/CT. 18F-FCH localized 11 additional foci (6 positive and 5 inconclusive) compared to 11C-MET. Twenty-six patients (sex F/M ratio16/10) underwent surgery with resection of 31 lesions (22 adenomas, 6 hyperplastic glands, 3 carcinomas) and 1 normal gland. At follow-up, twenty-one (81%) patients were considered cured after surgery, while 3 (12%) patients had persistence of hypercalcaemia. With inconclusive cases being considered as negative, 18F-FCH-PET/CT correctly localized 26 lesions in 24/26 (92%) patients compared to 16 lesions in 15/26 (58%) patients localized by 11C-MET-PET/CT. Per patient-based sensitivity and positive predictive value (PPV) were 96% and 96% for 18F-FCH and 60% and 94% for 11C-MET (p18F-FCH vs. 52% and 94% for 11C-MET (p18F-FCH-PET/CT has a better performance than 11C-MET-PET/CT for the detection of pathological parathyroid tissue, allowing localization of parathyroid adenoma or hyperplasia in 96% of patients.
- 19 August 2021
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 63 (5) , 785-791
18F-fluorocholine PET/CT is more sensitive than 11C-methionine PET/CT for the localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism
Purpose: Preoperative molecular imaging is paramount to direct surgery in primary hyperparathyroidism (pHTP). We investigate the diagnostic performance of 18F-fluorocholine (18F-FCH) PET/CT compared to 11C-methionine (11C-MET) PET/CT for the localization of hyperfunctioning parathyroid tissue in patients with pHTP and negative or inconclusive 99mTc-sestaMIBI SPECT (MIBI) findings. Materials and Methods: Fifty-eight patients with biochemical evidence of pHTP and negative or inconclusive MIBI were referred for pre-surgical detection and localization of hyperfunctioning parathyroid tissue by 11C-MET- and 18F-FCH-PET/CT. The PET/CT results were classified into 3 categories (positive, inconclusive or negative) based on the nodular aspect of tracer uptake and the visualisation of corresponding nodules on CT. The PET/CT results were correlated with the surgical and histopathological findings used as gold standard. Results: Fifty-three patients were included for analysis. 18F-FCH-PET/CT was positive in 39 patients (74%), inconclusive in 5 (9%) and negative in 9 (17%), compared to 25 (47%), 12 (23%) and 16 (30%) respectively for 11C-MET-PET/CT. 18F-FCH localized 11 additional foci (6 positive and 5 inconclusive) compared to 11C-MET. Twenty-six patients (sex F/M ratio16/10) underwent surgery with resection of 31 lesions (22 adenomas, 6 hyperplastic glands, 3 carcinomas) and 1 normal gland. At follow-up, twenty-one (81%) patients were considered cured after surgery, while 3 (12%) patients had persistence of hypercalcaemia. With inconclusive cases being considered as negative, 18F-FCH-PET/CT correctly localized 26 lesions in 24/26 (92%) patients compared to 16 lesions in 15/26 (58%) patients localized by 11C-MET-PET/CT. Per patient-based sensitivity and positive predictive value (PPV) were 96% and 96% for 18F-FCH and 60% and 94% for 11C-MET (p18F-FCH vs. 52% and 94% for 11C-MET (p18F-FCH-PET/CT has a better performance than 11C-MET-PET/CT for the detection of pathological parathyroid tissue, allowing localization of parathyroid adenoma or hyperplasia in 96% of patients.
- Open Access
The role of reading experience in atypical cortical tracking of speech and speech-in-noise in dyslexia
Dyslexia is a frequent developmental disorder in which reading acquisition is delayed and that is usually associated with difficulties understanding speech in noise. At the neuronal level, children with dyslexia were reported to display abnormal cortical tracking of speech (CTS) at phrasal rate. Here, we aimed to determine if abnormal tracking is a cause or a consequence of dyslexia and if it is modulated by the severity of dyslexia or the presence of acoustic noise. We included 26 school-age children with dyslexia, 26 age-matched controls and 26 reading-level matched controls. All were native French speakers. Children’s brain activity was recorded with magnetoencephalography while they listened to continuous speech in noiseless and multiple noise conditions. CTS values were compared between groups, conditions and hemispheres, and also within groups, between children with best and worse reading performance. Syllabic CTS was significantly reduced in the right superior temporal gyrus in children with dyslexia compared with controls matched for age but not for reading level. Among children with dyslexia, phrasal CTS tended to lateralize to the left hemisphere in severe dyslexia and lateralized to the right hemisphere in children with mild dyslexia and in all control groups. Finally, phrasal CTS was lower in children with dyslexia compared with age-matched controls, but only in informational noise conditions. No such effect was seen in comparison with reading-level matched controls. Overall, our results confirmed the finding of altered neuronal basis of speech perception in noiseless and babble noise conditions in dyslexia compared with age-matched peers. However, the absence of alteration in comparison with reading-level matched controls suggests that such alterations are a consequence of reduced reading experience rather than a cause of dyslexia. Highlights The cortical tracking of speech (CTS) was assessed in dyslexia and proper controls Phrasal CTS and its resistance to noise were altered in dyslexia Such alterations were not found in comparison with controls matched for reading level The severity of dyslexia modulated the hemispheric lateralization of phrasal CTS
Open AccessThe role of reading experience in atypical cortical tracking of speech and speech-in-noise in dyslexia
Dyslexia is a frequent developmental disorder in which reading acquisition is delayed and that is usually associated with difficulties understanding speech in noise. At the neuronal level, children with dyslexia were reported to display abnormal cortical tracking of speech (CTS) at phrasal rate. Here, we aimed to determine if abnormal tracking is a cause or a consequence of dyslexia and if it is modulated by the severity of dyslexia or the presence of acoustic noise. We included 26 school-age children with dyslexia, 26 age-matched controls and 26 reading-level matched controls. All were native French speakers. Children’s brain activity was recorded with magnetoencephalography while they listened to continuous speech in noiseless and multiple noise conditions. CTS values were compared between groups, conditions and hemispheres, and also within groups, between children with best and worse reading performance. Syllabic CTS was significantly reduced in the right superior temporal gyrus in children with dyslexia compared with controls matched for age but not for reading level. Among children with dyslexia, phrasal CTS tended to lateralize to the left hemisphere in severe dyslexia and lateralized to the right hemisphere in children with mild dyslexia and in all control groups. Finally, phrasal CTS was lower in children with dyslexia compared with age-matched controls, but only in informational noise conditions. No such effect was seen in comparison with reading-level matched controls. Overall, our results confirmed the finding of altered neuronal basis of speech perception in noiseless and babble noise conditions in dyslexia compared with age-matched peers. However, the absence of alteration in comparison with reading-level matched controls suggests that such alterations are a consequence of reduced reading experience rather than a cause of dyslexia. Highlights The cortical tracking of speech (CTS) was assessed in dyslexia and proper controls Phrasal CTS and its resistance to noise were altered in dyslexia Such alterations were not found in comparison with controls matched for reading level The severity of dyslexia modulated the hemispheric lateralization of phrasal CTS
- Open Access
Voxelwise Principal Component Analysis of Dynamic [S-Methyl-11C]Methionine PET Data in Glioma Patients
Recent works have demonstrated the added value of dynamic amino acid positron emission tomography (PET) for glioma grading and genotyping, biopsy targeting, and recurrence diagnosis. However, most of these studies are based on hand-crafted qualitative or semi-quantitative features extracted from the mean time activity curve within predefined volumes. Voxelwise dynamic PET data analysis could instead provide a better insight into intra-tumor heterogeneity of gliomas. In this work, we investigate the ability of principal component analysis (PCA) to extract relevant quantitative features from a large number of motion-corrected [S-methyl-11C]methionine ([11C]MET) PET frames. We first demonstrate the robustness of our methodology to noise by means of numerical simulations. We then build a PCA model from dynamic [11C]MET acquisitions of 20 glioma patients. In a distinct cohort of 13 glioma patients, we compare the parametric maps derived from our PCA model to these provided by the classical one-compartment pharmacokinetic model (1TCM). We show that our PCA model outperforms the 1TCM to distinguish characteristic dynamic uptake behaviors within the tumor while being less computationally expensive and not requiring arterial sampling. Such methodology could be valuable to assess the tumor aggressiveness locally with applications for treatment planning and response evaluation. This work further supports the added value of dynamic over static [11C]MET PET in gliomas.
Open AccessVoxelwise Principal Component Analysis of Dynamic [S-Methyl-11C]Methionine PET Data in Glioma Patients
Recent works have demonstrated the added value of dynamic amino acid positron emission tomography (PET) for glioma grading and genotyping, biopsy targeting, and recurrence diagnosis. However, most of these studies are based on hand-crafted qualitative or semi-quantitative features extracted from the mean time activity curve within predefined volumes. Voxelwise dynamic PET data analysis could instead provide a better insight into intra-tumor heterogeneity of gliomas. In this work, we investigate the ability of principal component analysis (PCA) to extract relevant quantitative features from a large number of motion-corrected [S-methyl-11C]methionine ([11C]MET) PET frames. We first demonstrate the robustness of our methodology to noise by means of numerical simulations. We then build a PCA model from dynamic [11C]MET acquisitions of 20 glioma patients. In a distinct cohort of 13 glioma patients, we compare the parametric maps derived from our PCA model to these provided by the classical one-compartment pharmacokinetic model (1TCM). We show that our PCA model outperforms the 1TCM to distinguish characteristic dynamic uptake behaviors within the tumor while being less computationally expensive and not requiring arterial sampling. Such methodology could be valuable to assess the tumor aggressiveness locally with applications for treatment planning and response evaluation. This work further supports the added value of dynamic over static [11C]MET PET in gliomas.
- 1 November 2020
- Published by Elsevier in Clinical Neurophysiology
- Vol. 131 (11) , 2713-2715
MEG and high-density EEG resting-state networks mapping in children
- 1 November 2020
- Published by Elsevier in Clinical Neurophysiology
- Vol. 131 (11) , 2713-2715
MEG and high-density EEG resting-state networks mapping in children